Home/Filings/4/0001946043-25-000002
4//SEC Filing

Kirkov Kirko 4

Accession 0001946043-25-000002

CIK 0001053369other

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 6:05 PM ET

Size

4.5 KB

Accession

0001946043-25-000002

Insider Transaction Report

Form 4
Period: 2025-07-10
Kirkov Kirko
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2025-07-10$0.59/sh+16,366$9,64016,366 total

Issuer

ELITE PHARMACEUTICALS INC /NV/

CIK 0001053369

Entity typeother

Related Parties

1
  • filerCIK 0001946043

Filing Metadata

Form type
4
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 6:05 PM ET
Size
4.5 KB